Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Leukemia, Myelomonocytic, Acute × veliparib × Clear all

Sponsor

Conditions

Breast Neoplasms 4 Small Cell Lung Carcinoma 3 Ovarian Neoplasms 3 Neoplasm Metastasis 3 Triple Negative Breast Neoplasms 2 Rectal Neoplasms 2 Gliosarcoma 2 Glioblastoma 2 Fallopian Tube Neoplasms 2 Colorectal Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Uterine Cervical Neoplasms 1 Thrombocythemia, Essential 1 Skin Neoplasms 1 Prostatic Neoplasms 1 Primary Myelofibrosis 1 Polycythemia Vera 1 Pancreatic Neoplasms 1 Oligodendroglioma 1 Neoplasms 1 Myelodysplastic-Myeloproliferative Diseases 1 Melanoma 1 Lymphoma, T-Cell 1 Lymphoma, Mantle-Cell 1 Liver Neoplasms 1 Leukemia, Myelomonocytic, Chronic 1 Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 1 Leukemia, Myeloid, Acute 1 Glioma 1 Ependymoma 1

Interventions

Cytarabine 22 Mitoxantrone 7 Idarubicin 7 fludarabine phosphate 6 Daunorubicin 6 Etoposide 5 alvocidib 4 Vorinostat 4 Tacrolimus 4 Peripheral Blood Stem Cell Transplantation 4 Methotrexate 4 Gemtuzumab 4 Filgrastim 4 Clofarabine 4 Busulfan 4 tipifarnib 3 Whole-Body Irradiation 3 Mycophenolic Acid 3 Decitabine 3 Bortezomib 3 Biopsy 3 Azacitidine 3 Antilymphocyte Serum 3 Sirolimus 2 Pravastatin 2 Observation 2 Flow Cytometry 2 Cyclosporine 2 trioctyl phosphine oxide 1 temsirolimus 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡